Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for Secondary Pulmonary Hypertension Due to Mitral Valve Dysfunction
NCT01270750Phase 2Unknown
- Sponsor
- General Hospital of Chalkida
- Start
- Dec 2010
- Primary completion
- Jun 2011
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bosentan in secondary pulmonary hypertension, sponsored by General Hospital of Chalkida. Status: unknown.
02
Drugs
bosentan
03
Conditions
secondary pulmonary hypertension
Beyond the preview
Go deeper on NCT01270750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270750.